疑似咽喉反流病患者质子泵抑制剂减停方案的可行性研究
结果显示66%患者减停后无症状,34%症状复发且其中92%需恢复PPI;高BMI是减停失败的显著预测因素(OR=0.72,95%CI 0.55-0.95)。
要点
- 约66%的LPRD患者经经验性治疗成功后可按标准化方案成功减停PPI。
- 减停后症状复发者中92%需重新使用PPI。
- 高BMI是PPI减停失败的显著预测因素(OR=0.72,95%CI 0.55-0.95)。
核心结论
- 约66%的LPRD患者经经验性治疗成功后可按标准化方案成功减停PPI。
- 高BMI是减停失败的显著预测因素(OR=0.72,95%CI 0.55-0.95)。
研究设计与样本
- 研究地点为三级喉科诊所,采用标准化减停方案。
主要发现
- 12例(34%)减停后症状复发,其中11例(92%)需重新使用PPI。
- 减停失败组中位随访13个月(范围6-29),成功组中位随访18个月(范围6-38)。
- 减停失败组减停前后RSI评分分别为7.7±5.6和12.9±6(P=.11);成功组分别为8.1±6.5和8.1±9.0(P<.99)。
- 控制年龄、性别、PPI治疗时长和PPI方案后,BMI是减停失败的显著预测因素(OR=0.72,95%CI 0.55-0.95),其他协变量均不显著。
临床怎么用
- 对经验性治疗有效的疑似LPRD患者可考虑按标准化方案尝试减停PPI。
- 高BMI患者减停失败风险较高,减停过程中需加强监测。
局限性
- 回顾性图表综述,证据等级为4级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the feasibility of a proton pump inhibitor (PPI) weaning protocol in a cohort of patients following successful empiric treatment for suspected laryngopharyngeal reflux disease (LPRD). STUDY DESIGN: Retrospective chart review. METHODS: LPRD patients were weaned from PPIs using a standardized weaning protocol. Symptom recurrence rate following PPI wean and present PPI use were determined. All numeric data were analyzed. The setting was a tertiary laryngology practice. The subjects were patients who had a positive response to empiric treatment for LPRD and subsequently were weaned from PPI therapy. RESULTS: Thirty-five patients with suspected LPRD were instructed to wean from PPI after successful empiric treatment of their LPRD symptoms from July 2013 to September 2015. Twenty-three patients (66%) remained symptom-free post-wean. Twelve patients (34%) had symptom recurrence post-wean; of those, 11 of them (92%) needed to go back on a PPI. Median durations of follow-up for the unsuccessful wean group and the successful wean group were 13 (range 6-29) months and 18 (range 6-38) months, respectively. Pre-wean and post-wean reflux symptom index (RSI) scores in the unsuccessful wean group were 7.7 ± 5.6 and 12.9 ± 6 (P = .11). Pre-wean and post-wean RSI scores in the successful wean group were 8.1 ± 6.5 and 8.1 ± 9.0 (P < .99). Body mass index (BMI) was found to be a significant predictor of failure to wean (odds ratio = 0.72, 95% confidence interval = 0.55-0.95) after controlling for age, sex, PPI treatment duration, and PPI regime. None of the other covariates were found to be significant predictors of failure of PPI wean. CONCLUSION: Approximately 66% of patients who were on PPIs for LPRD were successfully weaned. High BMI was significantly predictive of failure to wean. LEVEL OF EVIDENCE: 4. Laryngoscope, 128:133-137, 2018.
引用
- Lin RJ, Sridharan S, Smith LJ, et al. Weaning of proton pump inhibitors in patients with suspected laryngopharyngeal reflux disease. Laryngoscope. 2017. PMID: 28730666. doi:10.1002/lary.26696
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。